<?xml version="1.0" encoding="UTF-8"?>
<rdf:RDF xmlns:rdf="http://www.w3.org/1999/02/22-rdf-syntax-ns#" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:prism="http://prismstandard.org/namespaces/1.2/basic/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns="http://purl.org/rss/1.0/"><channel rdf:about="http://www.jecm-online.com//inpress?rss=yes"><title>Journal of Experimental &amp; Clinical Medicine - Articles in Press</title><description>Journal of Experimental &amp; Clinical Medicine RSS feed: Articles in Press.    The  Journal of Experimental and Clinical Medicine (JECM)  aims
to publish high quality scientific research in the field of 
experimental
and clinical medicine, with the goal of promoting and
disseminating medical science knowledge to improve global
health. 
 

Articles on clinical, laboratory and social research in medicine
and other related fields that are of interest to the medical
profession 
are eligible for consideration. The  JECM  publishes
review articles, original articles, case reports, short communications,
and 
letters to the editor. The journal is published
every 2 months, with a total of 6 issues a year.   </description><link>http://www.jecm-online.com//inpress?rss=yes</link><dc:publisher>Elsevier Inc.</dc:publisher><dc:language>en</dc:language><dc:rights> © 2012 Published by Elsevier Inc.  </dc:rights><prism:publicationName>Journal of Experimental &amp; Clinical Medicine</prism:publicationName><prism:issn>1878-3317</prism:issn><prism:publicationDate>2012-02-22</prism:publicationDate><prism:copyright> © 2012 Published by Elsevier Inc.  </prism:copyright><prism:rightsAgent>healthpermissions@elsevier.com</prism:rightsAgent><items><rdf:Seq><rdf:li rdf:resource="http://www.jecm-online.com/article/PIIS1878331712000216/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jecm-online.com/article/PIIS1878331712000241/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jecm-online.com/article/PIIS1878331711001690/abstract?rss=yes"/><rdf:li rdf:resource="http://www.jecm-online.com/article/PIIS187833171100091X/abstract?rss=yes"/></rdf:Seq></items></channel><item rdf:about="http://www.jecm-online.com/article/PIIS1878331712000216/abstract?rss=yes"><title>Promoting Mental Health and Resilience after a Disaster - Corrected Proof</title><link>http://www.jecm-online.com/article/PIIS1878331712000216/abstract?rss=yes</link><description>Until recently, mental health programs during and after disasters were considered to be controversial. A disaster exposes many people to extreme stresses and injury and illness. Especially in resource-poor countries, a disaster also brings a range of problems that erode protections, increase social injustice and inequality and entail human rights violations. There is a growing international consensus on the need for a range of mental health and social interventions integrated with existing systems. The mental health and psychosocial response programs increasingly integrated into humanitarian assistance programs can be seen as an opportunity to model the introduction of mental health centrally and explicitly in the public heath framework of a country. Mental health is a state of wellbeing in which a person can use their own abilities and cope with the normal stresses of life. It is promoted by effective public health and social interventions. Mental health and physical health and behavior are closely interconnected. These connections are important after a disaster. Resilience refers to a person’s relative resistance to, or the overcoming of, stress or adversity. Mental health and resilience depend on interactions between personal and wider social factors, such as safety and access to education and work. Effective interventions to promote mental health and resilience after a disaster focus on self-efficacy and community participation. Interventions occur at several levels, and alongside help provided to those with mental illnesses. They include social policies such as rebuilding housing and opening schools. They also include activities closer to the person, such as livelihood support to women and girls. A challenge now is to evaluate and refine programs and good practice after a disaster: monitoring the effects on mental health of activities in nonhealth sectors; and monitoring the effects on broader health and function of activities designed primarily to promote mental health.</description><dc:title>Promoting Mental Health and Resilience after a Disaster - Corrected Proof</dc:title><dc:creator>Helen Herrman</dc:creator><dc:identifier>10.1016/j.jecm.2012.01.003</dc:identifier><dc:source>Journal of Experimental &amp; Clinical Medicine (2012)</dc:source><dc:date>2012-02-22</dc:date><prism:publicationName>Journal of Experimental &amp; Clinical Medicine</prism:publicationName><prism:publicationDate>2012-02-22</prism:publicationDate><prism:section>REVIEW ARTICLE</prism:section></item><item rdf:about="http://www.jecm-online.com/article/PIIS1878331712000241/abstract?rss=yes"><title>Generalized Anxiety Disorder: A Review of Recent Findings - Corrected Proof</title><link>http://www.jecm-online.com/article/PIIS1878331712000241/abstract?rss=yes</link><description>Generalized anxiety disorder (GAD) is characterized by a pervasive cognitive dysfunction with a focus on threats and risks toward the individual or his/her immediate family. It goes with tension, worry, muscle pain, disturbed sleep, and irritability that all together impair work capacity, relations, and leisure activities. By its chronic course, GAD increases direct and indirect costs for the individual, the family, the health care services, and at work or in education. Among patients with cardiovascular or cerebrovascular disease, pulmonary disease, diabetes, and neurological diseases, GAD is a risk factor for somatic complications and for lowered adherence to somatic treatments. GAD can be treated with cognitive behavioral therapy, and/or with medications.</description><dc:title>Generalized Anxiety Disorder: A Review of Recent Findings - Corrected Proof</dc:title><dc:creator>Christer Allgulander</dc:creator><dc:identifier>10.1016/j.jecm.2012.01.006</dc:identifier><dc:source>Journal of Experimental &amp; Clinical Medicine (2012)</dc:source><dc:date>2012-02-22</dc:date><prism:publicationName>Journal of Experimental &amp; Clinical Medicine</prism:publicationName><prism:publicationDate>2012-02-22</prism:publicationDate><prism:section>REVIEW ARTICLE</prism:section></item><item rdf:about="http://www.jecm-online.com/article/PIIS1878331711001690/abstract?rss=yes"><title>A Duplex PCR-RFLP Assay for Simultaneous Detection of FV Leiden and Prothrombin G20210A Mutations in Women with Recurrent Spontaneous Abortion - Corrected Proof</title><link>http://www.jecm-online.com/article/PIIS1878331711001690/abstract?rss=yes</link><description>Factor V Leiden (FV-Leiden) and prothrombin gene mutations (FII G20210A) are well-established independent risk factors for several pregnancy complications and may be associated with an increased risk of recurrent spontaneous abortion. Molecular diagnosis testing for both mutations is widespread and need to be standardized. We have optimized a duplex polymerase chain reaction-restriction fragment length polymorphism assay (PCR-RFLP) for the simultaneous detection of both mutations in a single-tube single-enzyme digestion reaction for 35 women with recurrent spontaneous abortion. This assay is a convenient method that should be applied in routine settings for detecting thrombophilia in women who are suffering from recurrent spontaneous abortion.</description><dc:title>A Duplex PCR-RFLP Assay for Simultaneous Detection of FV Leiden and Prothrombin G20210A Mutations in Women with Recurrent Spontaneous Abortion - Corrected Proof</dc:title><dc:creator>Rim Frikha, Nouha Bouayed Abdelmoula, Tarek Rebai</dc:creator><dc:identifier>10.1016/j.jecm.2011.11.015</dc:identifier><dc:source>Journal of Experimental &amp; Clinical Medicine (2011)</dc:source><dc:date>2011-12-26</dc:date><prism:publicationName>Journal of Experimental &amp; Clinical Medicine</prism:publicationName><prism:publicationDate>2011-12-26</prism:publicationDate><prism:section>SHORT COMMUNICATION</prism:section></item><item rdf:about="http://www.jecm-online.com/article/PIIS187833171100091X/abstract?rss=yes"><title>WITHDRAWN: Epidemiology of Eye Diseases Among Ethnic Chinese: Data From the Shihpai Eye Study - Corrected Proof</title><link>http://www.jecm-online.com/article/PIIS187833171100091X/abstract?rss=yes</link><description>This article has been withdrawn as an updated version of the same article will be published shortly. The DOI of the new version is: 10.1016/j.jecm.2011.07.007.The Publisher apologizes for any inconvenience this may cause.The full Elsevier Policy on Article Withdrawal can be found at http://www.elsevier.com/locate/withdrawalpolicy</description><dc:title>WITHDRAWN: Epidemiology of Eye Diseases Among Ethnic Chinese: Data From the Shihpai Eye Study - Corrected Proof</dc:title><dc:creator>Wen-Ming Hsu</dc:creator><dc:identifier>10.1016/j.jecm.2011.07.001</dc:identifier><dc:source>Journal of Experimental &amp; Clinical Medicine (2011)</dc:source><dc:date>2011-08-16</dc:date><prism:publicationName>Journal of Experimental &amp; Clinical Medicine</prism:publicationName><prism:publicationDate>2011-08-16</prism:publicationDate></item></rdf:RDF>
